US-based clinical diagnostic laboratory Personalis has entered a partnership with the Louisiana State University Health Sciences Center New Orleans Precision Medicine programme to provide comprehensive clinical genomic testing for tumour profiling and inherited genetic diseases.

Under the deal, Personalis will carry out clinical cancer testing and research services through its ACE CancerPlus test, which combines both DNA and RNA sequencing of more than 1,300 genes and uses the company’s ACE technology.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The testing will provide comprehensive tumour genomic profile data to guide therapy and ongoing research at the LSU Health New Orleans Precision Medicine programme.

Personalis chief scientific officer Dr Richard Chen said: "We are thrilled to work together with the LSU Health New Orleans Precision Medicine programme to provide our comprehensive, high accuracy genomic tests to their patients with cancer and genetic disorders.

"Working with LSU Health New Orleans, we want to provide the best possible care to patients by bringing genomics-based precision medicine to the bedside."

"Working with LSU Health New Orleans, we want to provide the best possible care to patients by bringing genomics-based precision medicine to the bedside.

"Not only will this partnership bring benefits to patients, but it will also bring the substantial medical and scientific expertise at the two institutions together in a research capacity that will benefit future patients."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In addition, the company will provide its ACE Clinical Exome test for the diagnosis of genetic disorders in paediatric and adult patients.

The ACE Clinical Exome Test targets essentially all human genes using the company’s ACE exome technology.

Personalis provides advanced genome sequencing and interpretation services to clinicians and researchers for cancer and inherited genetic diseases.